Back
Plus Therapeutics Stock Price Chart
Sponsored
PSTV
Sponsored
The little-known AI stock you need to read about now...
Get the name - FREE.
Sell
17
PSTV
Plus Therapeutics
Last Price:
1.64
Seasonality Move:
-15.5%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight buying pressure.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.69 | Sell |
20-day SMA: | 1.79 | Sell |
50-day SMA: | 1.84 | Sell |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 1.69 | Sell |
20-day EMA: | 1.76 | Sell |
50-day EMA: | 1.82 | Sell |
200-day EMA: | 2.37 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 34.5 | Sell |
Chaikin Money Flow: | 2010 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.72 - 1.9) | Sell |
Bollinger Bands (100): | (1.76 - 2.06) | Sell |
Plus Therapeutics Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.60 while PSTV 8-day simple moving average is 1.69, which is a Sell signal.
- The stock price of PSTV is 1.60 while Plus Therapeutics 20-day SMA is 1.79, which makes it a Sell.
- Plus Therapeutics 50-day simple moving average is 1.84 while PSTV share price is 1.60, making it a Sell technically.
- PSTV stock price is 1.60 and Plus Therapeutics 200-day simple moving average is 1.88, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
17
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a Sell
The current Plus Therapeutics [PSTV] share price is $1.60. The Score for PSTV is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
6.97M
Price in USD:
1.60
Share Volume:
8.44K
Plus Therapeutics 52-Week Range
52-Week High:
5.09
52-Week Low:
0.97
Sell
17
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?
The Plus Therapeutics stock price is 1.60 USD today. -
Will PSTV stock go up or go down?
Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Plus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.60 while PSTV 8-day exponential moving average is 1.69, which is a Sell signal.
- The stock price of PSTV is 1.60 while Plus Therapeutics 20-day EMA is 1.76, which makes it a Sell.
- Plus Therapeutics 50-day exponential moving average is 1.82 while PSTV share price is 1.60, making it a Sell technically.
- PSTV stock price is 1.60 and Plus Therapeutics 200-day simple moving average is 2.37, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.04 per share, an increase this year of $2.58 per share, and an increase next year of $0.41 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
- PSTV Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Plus Therapeutics is a Sell
- Plus Therapeutics Relative Strength Index (RSI) is 34.5, which suggest Plus Therapeutics is oversold
- The Bollinger Bands (25) for Plus Therapeutics is (1.72 - 1.9), which suggest Plus Therapeutics is a Sell
- The Bollinger Bands (100) for Plus Therapeutics is (1.76 - 2.06), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.